메뉴 건너뛰기




Volumn 36, Issue 3, 2008, Pages 449-457

Flaws in the U.S. food and drug administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients

Author keywords

[No Author keywords available]

Indexed keywords

HYDRALAZINE; ISOSORBIDE DINITRATE; ISOSORBIDE HYDRALAZINE COMBINATION; ISOSORBIDE-HYDRALAZINE COMBINATION; VASODILATOR AGENT;

EID: 50249149724     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2008.290.x     Document Type: Conference Paper
Times cited : (24)

References (45)
  • 1
    • 33846928249 scopus 로고    scopus 로고
    • BiDil for Heart Failure in Black Patients: The U.S. Food and Drug Administration Perspective
    • and
    • R. Temple and N. L. Stockbridge BiDil for Heart Failure in Black Patients: The U.S. Food and Drug Administration Perspective Annals of Internal Medicine 146, no. 1 (2007 57 62.
    • (2007) Annals of Internal Medicine , vol.146 , Issue.1 , pp. 57-62
    • Temple, R.1    Stockbridge, N.L.2
  • 3
    • 33846906275 scopus 로고    scopus 로고
    • BiDil for Heart Failure in Black Patients: Implications of the U.S. Food and Drug Administration Approval
    • and
    • K. Bibbins-Domingo and A. Fernandez BiDil for Heart Failure in Black Patients: Implications of the U.S. Food and Drug Administration Approval Annals of Internal Medicine 146, no. 1 (2007 52 56.
    • (2007) Annals of Internal Medicine , vol.146 , Issue.1 , pp. 52-56
    • Bibbins-Domingo, K.1    Fernandez, A.2
  • 4
    • 50249085970 scopus 로고    scopus 로고
    • Id.
    • Id.
  • 5
    • 2142718229 scopus 로고    scopus 로고
    • How a Drug Becomes 'Ethnic': Law, Commerce, and the Production of Racial Categories in Medicine
    • J. Kahn How a Drug Becomes 'Ethnic': Law, Commerce, and the Production of Racial Categories in Medicine Yale Journal of Health Policy, Law & Ethics 4, no. 1 (2004 1 46.
    • (2004) Yale Journal of Health Policy, Law & Ethics , vol.4 , Issue.1 , pp. 1-46
    • Kahn, J.1
  • 7
    • 21244504609 scopus 로고    scopus 로고
    • Population Profiling and Public Health Risk: When and How Should We Use Race/Ethnicity
    • G. T. H. Ellison Population Profiling and Public Health Risk: When and How Should We Use Race/Ethnicity Critical Public Health 15, no. 1 (2005 65 74.
    • (2005) Critical Public Health , vol.15 , Issue.1 , pp. 65-74
    • Ellison, G.T.H.1
  • 8
    • 50249091523 scopus 로고    scopus 로고
    • See Temple and Stockbridge, supra note 1.
    • See Temple and Stockbridge, supra note 1.
  • 9
    • 50249152345 scopus 로고    scopus 로고
    • Id.
    • Id.
  • 10
    • 0032836517 scopus 로고    scopus 로고
    • Racial Differences in Response to Therapy for Heart Failure: Analysis of the Vasodilator-Heart Failure Trials
    • and
    • P. Carson, S. Ziesche, G. Johnson, and J. Cohn Racial Differences in Response to Therapy for Heart Failure: Analysis of the Vasodilator-Heart Failure Trials Journal of Cardiac Failure 5, no. 3 (1999 178 187.
    • (1999) Journal of Cardiac Failure , vol.5 , Issue.3 , pp. 178-187
    • Carson, P.1    Ziesche, S.2    Johnson, G.3    Cohn, J.4
  • 11
    • 50249149471 scopus 로고    scopus 로고
    • See Bibbins-Domingo and Fernandez, supra note 3.
    • See Bibbins-Domingo and Fernandez, supra note 3.
  • 12
    • 0022623381 scopus 로고
    • Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure: Results of a Veterans Administration Cooperative Study
    • and. and
    • J. N. Cohn, D. G. Archibald, S. Ziesche, F. Cobb, J. A. Franciosa, and W E. Harston et al. Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure: Results of a Veterans Administration Cooperative Study New England Journal of Medicine 314, no. 24 (1986 1547 1552 J. N. Cohn, G. Johnson, S. Ziesche, F. Cobb, G. Francis, and F. Tristani et al. A Comparison of Enalapril with Hydralazine-Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure New England Journal of Medicine 325, no. 5 (1991 303 310.
    • (1986) New England Journal of Medicine , vol.314 , Issue.24 , pp. 1547-1552
    • Cohn, J.N.1    Archibald, D.G.2    Ziesche, S.3    Cobb, F.4    Franciosa, J.A.5    Harston, W.E.6
  • 13
    • 50249177015 scopus 로고    scopus 로고
    • See Kahn, supra note 5.
    • See Kahn, supra note 5.
  • 14
    • 50249116679 scopus 로고    scopus 로고
    • See Bibbins-Domingo and Fernandez, supra note 3.
    • See Bibbins-Domingo and Fernandez, supra note 3.
  • 15
    • 50249142873 scopus 로고    scopus 로고
    • Statistics in Medicine: Reporting of Subgroup Analyses in Clinical Trials
    • and. and
    • G. T. H. Ellison Medicine in Black and White: BiDil, Race and the Limits of Evidence-Based Medicine Significance 3, no. 3 (2006 118 121 D. Kent and R. Hayward When Averages Hide Individual Differences in Clinical Trials American Scientist 95, no. 1 (2007 60 68 R. Wang, S. W Lagakos, J. H. Ware, D. J. Hunter, and J. M. Drazen Statistics in Medicine: Reporting of Subgroup Analyses in Clinical Trials New England Journal of Medicine 357, no. 21 (2007 2189 2194.
    • (2006) New England Journal of Medicine , vol.3 , Issue.3 , pp. 118-121
    • Ellison, G.T.H.1    Kent, D.2    Hayward, R.3    Wang, R.4    Lagakos, S.W.5    Ware, J.H.6    Hunter, D.J.7    Drazen, J.M.8
  • 19
    • 50249115041 scopus 로고    scopus 로고
    • See. and. supra note 15.
    • See Kent and Hayward, supra note 15.
    • Kent1    Hayward2
  • 21
    • 50249123365 scopus 로고    scopus 로고
    • Id.
    • Id.
  • 22
    • 0023275910 scopus 로고
    • Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: Influence of Pre-Random-ization Variables on the Reduction of Mortality by Treatment with Hydralazine and Isosorbide Dinitrate
    • See. and. supra note 12. and. supra note 12. and. and
    • See Cohn, Archibald, Ziesche, Cobb, Franciosa, and Harston et al., supra note 12 Cohn, Johnson, Ziesche, Cobb, Francis, and Tristani et al., supra note 12 J. N. Cohn, D. G. Archibald, G. S. Francis, S. Ziesche, J. A. Franciosa, and W E. Harston et al. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: Influence of Pre-Random-ization Variables on the Reduction of Mortality by Treatment with Hydralazine and Isosorbide Dinitrate Circulation 75, no. 5 (1987 IV49 IV54. G. Johnson, P. Carson, G. S. Francis, and J. N. Cohn Influence of Pre-Randomisation (Baseline) Variables on Mortality and on the Reduction of Mortality by Enalapril: Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II) Circulation 87, no. 6 (1993 VI32 VI39.
    • (1987) Circulation , vol.75 , Issue.5
    • Cohn1    Archibald2    Ziesche3    Cobb4    Franciosa5    Harston6
  • 24
    • 50249182810 scopus 로고    scopus 로고
    • Id.
    • Id. (Carson et al.).
    • Carson1
  • 25
    • 50249112609 scopus 로고    scopus 로고
    • Id.
    • Id.
  • 26
    • 0035880883 scopus 로고    scopus 로고
    • Considerations for Use of Racial/Ethnic Classification in a Etiologic Research
    • and
    • J. S. Kaufman and R. S. Cooper Considerations for Use of Racial/Ethnic Classification in a Etiologic Research American Journal of Epidemiology 514, no. 4 (2001 291 298.
    • (2001) American Journal of Epidemiology , vol.514 , Issue.4 , pp. 291-298
    • Kaufman, J.S.1    Cooper, R.S.2
  • 28
    • 23044445116 scopus 로고    scopus 로고
    • Management of Hypertension in Ethnic Minorities
    • and
    • J. M. Khan and D. G. Beevers Management of Hypertension in Ethnic Minorities Heart 91, no. 8 (2005 1105 1109.
    • (2005) Heart , vol.91 , Issue.8 , pp. 1105-1109
    • Khan, J.M.1    Beevers, D.G.2
  • 29
    • 50249102700 scopus 로고    scopus 로고
    • See. and. supra note 1.
    • See Temple and Stockbridge, supra note 1.
    • Temple1    Stockbridge2
  • 30
    • 50249163688 scopus 로고    scopus 로고
    • Id.
    • Id.
  • 31
    • 50249164760 scopus 로고    scopus 로고
    • Id.
    • Id.
  • 32
    • 0033975515 scopus 로고    scopus 로고
    • Census, Race and Science
    • See. supra note 7; Editorial
    • See Ellison, supra note 7; Editorial Census, Race and Science Nature Genetics 24, no. 2 (2000 97 98.
    • (2000) Nature Genetics , vol.24 , Issue.2 , pp. 97-98
    • Ellison1
  • 33
    • 50249183964 scopus 로고    scopus 로고
    • See. supra note 5.
    • See Kahn, supra note 5.
    • Kahn1
  • 34
    • 50249104360 scopus 로고    scopus 로고
    • See. and. supra note 1, at 58. 37. See. supra note 7.
    • See Temple and Stockbridge, supra note 1, at 58. 37. See Ellison, supra note 7.
    • Temple1    Stockbridge2    Ellison3
  • 35
    • 50249159081 scopus 로고    scopus 로고
    • See. and. supra note 1, at 61.
    • See Temple and Stockbridge, supra note 1, at 61.
    • Temple1    Stockbridge2
  • 36
    • 51249157424 scopus 로고    scopus 로고
    • Scientifically Correct Racism: Health Studies' Unintentional Effects Against Minority Groups
    • See also. and
    • See also D. La Parra Casado and A. M. Perez Scientifically Correct Racism: Health Studies' Unintentional Effects Against Minority Groups Language and Intercultural Communication 7, no. 2 (2007 152 162.
    • (2007) Language and Intercultural Communication , vol.7 , Issue.2 , pp. 152-162
    • La Parra Casado, D.1    Perez, A.M.2
  • 37
    • 50249095049 scopus 로고
    • NIH Revitalization Act, Pub. L. No. 103-43 (
    • NIH Revitalization Act, Pub. L. No. 103-43 (1993).
    • (1993)
  • 38
    • 50249084964 scopus 로고    scopus 로고
    • See Temple and Stockbridge, supra note 1, at 60.
    • See Temple and Stockbridge, supra note 1, at 60.
  • 39
    • 50249093209 scopus 로고    scopus 로고
    • Id., at 60.
    • Id., at 60.
  • 40
    • 50249178141 scopus 로고    scopus 로고
    • See. supra note 5.
    • See Kahn, supra note 5.
    • Kahn1
  • 41
    • 50249178535 scopus 로고    scopus 로고
    • SeeNitroMed Reports Financial Results for First Fiscal Quarter 2008. availaible at. (last visited May 20, 2008).
    • See NitroMed Reports Financial Results for First Fiscal Quarter 2008 availaible at http://phx.corporate-ir.net/phoenix.zhtml?c=130535&p=irol- newsArticle&ID=1141115&highlight= (last visited May 20, 2008).
  • 42
    • 50249115040 scopus 로고    scopus 로고
    • See Temple and Stockbridge, supra note 1, at 61.
    • See Temple and Stockbridge, supra note 1, at 61.
  • 44
    • 50249172194 scopus 로고    scopus 로고
    • See Temple and Stockbridge, supra note 1, at 61.
    • See Temple and Stockbridge, supra note 1, at 61.
  • 45
    • 50249149470 scopus 로고    scopus 로고
    • Center for Drug Evaluation and Research, "Approval Package for: Application Number NDA 20-727. Administrative/Correspondence Reviews. Nd.," available at. (last visited
    • Center for Drug Evaluation and Research, "Approval Package for: Application Number NDA 20-727. Administrative/Correspondence Reviews. Nd.," available at http://www.fda.gov/cder/foi/nda/2005/ 020727_S000_Bidil_AdminCorres.pdf (last visited May 19, 2008).
    • (2008)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.